Marcelo Linhares

Marcelo Linhares


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in Annals of Surgery
Verified
Journal Article
Closed access
DADaniel Azoulay
Daniel Azoulay
MLMarcelo Linhares
Marcelo Linhares
EHEmmanuel Md Huguet
Emmanuel Md Huguet
VDValérie Delvart
Valérie Delvart
DCDenis Castaing
Denis Castaing
HBHenri Md Bismuth
Henri Md Bismuth
Objective To determine the patient factors affecting patient outcome of first liver retransplantation at a single center to help in the decision process for retransplantation. Summary Background Data Given the critical organ shortage, one of the most controversial questions is whether hepatic retransplantation, the only chance of survival for patients with a failing first organ, should be offered liberally despite its greater cost, worse survival, and the inevitable denial of access to primary transplantation to other patients due to the depletion of an already-limited organ supply. The authors’ experience of 139 consecutive retransplantations was reviewed to evaluate the results of retransplantation and to identify the factors that could improve the results. Methods From 1986 to 2000, 1,038 patients underwent only one liver transplant and 139 patients underwent a first retransplant at the authors’ center (first retransplantation rate = 12%). Multivariate analysis was performed to identify variables, excluding intraoperative and donor variables, associated with graft and patient long-term survival following first retransplantation. Lengths of hospital and intensive care unit stay and hospital charges incurred during the transplantation admissions were compared for retransplanted patients and primary-transplant patients. Results One-year, 5-year, and 10-year graft and patient survival rates following retransplantation were 54.0%, 42.5%, 36.8% and 61.2%, 53.7%, and 50.1%, respectively. These percentages were significantly less than those following a single hepatic transplantation at the authors’ center during the same period (82.3%, 72.1%, and 66.9%, respectively). On multivariate analysis, three patient variables were significantly associated with a poorer patient outcome: urgency of retransplantation (excluding primary nonfunction), age, and creatinine. Primary nonfunction as an indication for retransplantation, total bilirubin, and factor II level were associated with a better prognosis. The final model was highly predictive of survival: according to the combination of the factors affecting outcome, 5-year patient survival rates varied from 15% to 83%. Retransplant patients had significantly longer hospital and intensive care unit stays and accumulated significantly higher total hospital charges than those receiving only one transplant. Conclusions These data confirm the utility of retransplantation in the elective situation. In the emergency setting, retransplantation should be used with discretion, and it should be avoided in subgroups of patients with little chance of success.

1 December 2002 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
RARené Adam
René Adam
EHEllen J. Hagopian
Ellen J. Hagopian
MLMarcelo Linhares
Marcelo Linhares
JKJinane Krissat
Jinane Krissat
ESEric Savier
Eric Savier
HBHenri Bismuth
Henri Bismuth
HEPATIC RESECTION is the treatment of choice for hepatic malignancy; however, this may be achieved in fewer than 30% of those with primary1,2 and in 10% to 20% of those with secondary hepatic malignancies.1,3,4 Hepatic resection may be contraindicated because of multifocal bilateral disease, tumor proximity to major vascular or biliary structures, technical inaccessibility of the tumor because of previous hepatectomy, or inadequate functional hepatic reserve related to coexistent cirrhosis. For these groups of patients, other techniques of therapy have been explored. In situ techniques for the destruction of tumors, such as cryosurgery and radiofrequency, are accepted as alternative therapies for those with unresectable hepatic malignancies.

1 March 2013 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
Orlando MartinsOrlando Martins
Orlando Martins
EFEduardo de Souza Martins Fernandes
Eduardo de Souza Martins Fernandes
COCassio Virgilio Cavalcante Oliveira
Cassio Virgilio Cavalcante Oliveira
CLCristiano Xavier Lima
Cristiano Xavier Lima
FWFabio Luiz Waechter
Fabio Luiz Waechter
MMMarcel Autran Cesar Machado
Marcel Autran Cesar Machado
RACIONAL: Insuficiência hepática pós-operatória devido à remanescente hepático pequeno tem sido complicação temida em pacientes que são submetidos à ressecção hepática extensa. A ligadura da veia porta associada à bipartição do fígado para hepatectomia em dois estágios (ALPPS) foi desenvolvida recentemente com a finalidade de induzir rápida e significante regeneração do fígado para pacientes em que o tumor é previamente considerado irressecável. OBJETIVO: Apresentar a experiência brasileira com o ALPPS. MÉTODO: Foram analisados 39 pacientes submetidos ao procedimento ALPPS em nove hospitais. Ele foi realizado em duas etapas. A primeira operação consistiu em ligadura do ramo direito da veia porta e bipartição hepática. Na segunda, os ramos direito da artéria hepática, via biliar e veia hepática foram ligados e o lobo hepático direito estendido foi removido. Foram 22 pacientes do sexo masculino (56,4%) e 17 do feminino (43,6%). A média de idade foi 57,3 anos (variando de 20 a 83 anos). RESULTADOS: A indicação mais comum foi metástase hepática em 32 pacientes (82,0%), seguida por colangiocarcinoma em três pacientes (7,7%). Dois morreram neste intervalo e não foram submetidos à segunda operação. O intervalo médio da primeira para a segunda operação foi de 14,1 dias (variando de 5-30 dias). O volume do segmento lateral esquerdo apresentou aumento de 83% (variando de 47-211,9%). Morbidade significante foi observada em 23 pacientes (59,0%). A mortalidade foi de 12,8% (cinco pacientes). CONCLUSÃO: O procedimento ALPPS permite ressecção hepática em pacientes com lesões consideradas previamente irressecáveis por induzir rápida hipertrofia do fígado evitando a insuficiência hepática na maioria dos pacientes. Porém ainda apresenta elevada morbidade e mortalidade.

1 April 2006 in Transplantation
Verified
Journal Article
Closed access
MLMarcelo Linhares
Marcelo Linhares
DADaniel Azoulay
Daniel Azoulay
DMDélcio Matos
Délcio Matos
ACAdauto Castelo-Filho
Adauto Castelo-Filho
TTTarcísio Triviño
Tarcísio Triviño
HBHenry Bismuth
Henry Bismuth
Because of the worse results from retransplantation in relation to the initial liver transplantation, there is a need to refine the indication for retransplantation, such that fair distribution of this benefit is obtained. This was a study of 139 patients who underwent liver retransplantation. Thirty variables were studied: 18 relating to the recipient and 12 to the donor. All the independent variables were initially compared with the length of survival using univariate analyses. Variables presenting significance were compared with the dependent variable of length of survival, to determine which factors were related to longer survival among patients, when evaluated together. A multivariate model for determining long-term survival among patients with retransplants was built up using the following variables: recipient's age, creatinine, urgency of retransplantation and early failure of the first graft. Through this multivariate model it was possible to determine a score that was categorized according to tertile distributions (below the 33rd percentile, score 32). One-year, 3-year, and 5-year patient survival rates following retransplantation were respectively 85%, 82%, and 77% for scores 32 (P<0.0001). The variables of recipient's age, creatinine, urgency of retransplantation, and early failure of the initial transplantation were factors that were independently related to the long-term survival of patients with liver retransplants.

1 May 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
MLMarcelo Linhares
Marcelo Linhares
AGA.M Gonzalez
A.M Gonzalez
TTT Triviño
T Triviño
MBM.M.L.S Barbosa
M.M.L.S Barbosa
VSV Schraibman
V Schraibman
JPJ.O.M Pestana
J.O.M Pestana

1 May 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
MLMarcelo Linhares
Marcelo Linhares
AGA.M Gonzalez
A.M Gonzalez
SGS.M Goldman
S.M Goldman
RCR.D.S Coelho
R.D.S Coelho
NSN.Y Sato
N.Y Sato
TTT Triviño
T Triviño